{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:24:34Z","timestamp":1793942674326,"version":"4.8.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Chlamydia pneumoniae<\/jats:italic>\n                    is an intracellular bacterium implicated in Alzheimer\u2019s disease (AD), but its role in retinal pathology and disease progression is unclear. Here we identify\n                    <jats:italic>Chlamydia pneumoniae<\/jats:italic>\n                    inclusions in the retina, showing higher burden in AD retina and brain, increasing with APOE\u03b54, disease stage, and cognitive deficit. Retinal and cortical proteomics reveal bacterial-infection and related NLRP3-inflammasome pathways. Retinal NLRP3 is elevated in mild cognitive impairment and activated in AD dementia, evidenced by increased caspase-1, cleaved interleukin-1\u03b2, and cleaved N-terminal gasdermin-D.\n                    <jats:italic>Chlamydia pneumoniae<\/jats:italic>\n                    associates with amyloid-\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    , inflammation, apoptosis, pyroptosis, and AD status. In neuronal cultures and APP\n                    <jats:sub>SWE<\/jats:sub>\n                    \/PS1\n                    <jats:sub>\u0394E9<\/jats:sub>\n                    model mice, infection induces amyloid-\u03b2, inflammasome activation, neuroinflammation, and neurotoxicity, and chronic infection worsens cognition. Fewer pathogen-colocalized microglia are found in AD retinas, implying impaired clearance. Machine learning detects retinal\n                    <jats:italic>Chlamydia pneumoniae<\/jats:italic>\n                    or NLRP3, combined with amyloid-\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    , as predictors of AD diagnosis and stage. These findings support a disease-amplifying role for\n                    <jats:italic>Chlamydia pneumoniae<\/jats:italic>\n                    and propose NLRP3-attenuation or antibiotic-based early interventions.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-68580-4","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T10:02:44Z","timestamp":1769076164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer\u2019s disease retina"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-6493","authenticated-orcid":false,"given":"Bhakta Prasad","family":"Gaire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Koronyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Vit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7661-686X","authenticated-orcid":false,"given":"Alexandre","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalita","family":"Subedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieu-Trang","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altan","family":"Rentsendorj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0576-9383","authenticated-orcid":false,"given":"Saba","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Martinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2398-5319","authenticated-orcid":false,"given":"Alexander V.","family":"Ljubimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-1752","authenticated-orcid":false,"given":"Julie A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Hawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7519-969X","authenticated-orcid":false,"given":"Stuart L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0546-4934","authenticated-orcid":false,"given":"Keith L.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-3926","authenticated-orcid":false,"given":"Jesse G.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-2909","authenticated-orcid":false,"given":"Moshe","family":"Arditi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-6127","authenticated-orcid":false,"given":"Timothy R.","family":"Crother","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-8442","authenticated-orcid":false,"given":"Maya","family":"Koronyo-Hamaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"68580_CR1","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 20, 3708\u20133821, (2024).","DOI":"10.1002\/alz.13809"},{"key":"68580_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-023-00369-7","volume":"12","author":"CSG Catumbela","year":"2023","unstructured":"Catumbela, C. S. G., Giridharan, V. V., Barichello, T. & Morales, R. Clinical evidence of human pathogens implicated in Alzheimer\u2019s disease pathology and the therapeutic efficacy of antimicrobials: an overview. Transl. Neurodegener. 12, 37 (2023).","journal-title":"Transl. Neurodegener."},{"key":"68580_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jmv.1890330403","volume":"33","author":"GA Jamieson","year":"1991","unstructured":"Jamieson, G. A., Maitland, N. J., Wilcock, G. K., Craske, J. & Itzhaki, R. F. Latent herpes simplex virus type 1 in normal and Alzheimer\u2019s disease brains. J. Med. Virol. 33, 224\u2013227 (1991).","journal-title":"J. Med. Virol."},{"key":"68580_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","volume":"99","author":"B Readhead","year":"2018","unstructured":"Readhead, B. et al. Multiscale analysis of independent Alzheimer\u2019s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron 99, 64\u201382 e67 (2018).","journal-title":"Neuron"},{"key":"68580_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.14462","volume":"17","author":"ZAP Williams","year":"2024","unstructured":"Williams, Z. A. P. et al. Do microbes play a role in Alzheimer\u2019s disease?. Micro. Biotechnol. 17, e14462 (2024).","journal-title":"Micro. Biotechnol."},{"key":"68580_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fnagi.2018.00302","volume":"10","author":"BJ Balin","year":"2018","unstructured":"Balin, B. J. et al. Chlamydia pneumoniae: an etiologic agent for late-onset dementia. Front. Aging Neurosci. 10, 302 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"68580_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1393293","volume":"18","author":"L Subedi","year":"2024","unstructured":"Subedi, L., Gaire, B. P., Koronyo, Y., Koronyo-Hamaoui, M. & Crother, T. R. Chlamydia pneumoniae in Alzheimer\u2019s disease pathology. Front. Neurosci. 18, 1393293 (2024).","journal-title":"Front. Neurosci."},{"key":"68580_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbi.2019.10.014","volume":"83","author":"JJ Woods","year":"2020","unstructured":"Woods, J. J. et al. Assessment of evidence for or against contributions of Chlamydia pneumoniae infections to Alzheimer\u2019s disease etiology. Brain Behav. Immun. 83, 22\u201332 (2020).","journal-title":"Brain Behav. Immun."},{"key":"68580_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/ADR-170017","volume":"1","author":"CJ Carter","year":"2017","unstructured":"Carter, C. J. Genetic, transcriptome, proteomic, and epidemiological evidence for blood-brain barrier disruption and polymicrobial brain invasion as determinant factors in Alzheimer\u2019s disease. J. Alzheimers Dis. Rep. 1, 125\u2013157 (2017).","journal-title":"J. Alzheimers Dis. Rep."},{"key":"68580_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s004300050071","volume":"187","author":"BJ Balin","year":"1998","unstructured":"Balin, B. J. et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer\u2019s brain. Med. Microbiol. Immunol. 187, 23\u201342 (1998).","journal-title":"Med. Microbiol. Immunol."},{"key":"68580_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijmm.2008.07.002","volume":"299","author":"U Dreses-Werringloer","year":"2009","unstructured":"Dreses-Werringloer, U. et al. Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain. Int. J. Med. Microbiol. 299, 187\u2013201 (2009).","journal-title":"Int. J. Med. Microbiol."},{"key":"68580_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1574-695X.2006.00154.x","volume":"48","author":"HC Gerard","year":"2006","unstructured":"Gerard, H. C. et al. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer\u2019s brain. FEMS Immunol. Med. Microbiol. 48, 355\u2013366 (2006).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"68580_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-11-121","volume":"11","author":"CJ Hammond","year":"2010","unstructured":"Hammond, C. J. et al. Immunohistological detection of Chlamydia pneumoniae in the Alzheimer\u2019s disease brain. BMC Neurosci. 11, 121 (2010).","journal-title":"BMC Neurosci."},{"key":"68580_CR14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3233\/JAD-140621","volume":"43","author":"P Maheshwari","year":"2015","unstructured":"Maheshwari, P. & Eslick, G. D. Bacterial infection and Alzheimer\u2019s disease: a meta-analysis. J. Alzheimers Dis. 43, 957\u2013966 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"68580_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00415-006-0298-5","volume":"254","author":"B Paradowski","year":"2007","unstructured":"Paradowski, B., Jaremko, M., Dobosz, T., Leszek, J. & Noga, L. Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer\u2019s disease and vascular dementia. J. Neurol. 254, 154\u2013159 (2007).","journal-title":"J. Neurol."},{"key":"68580_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/psyg.12163","volume":"16","author":"T Manabe","year":"2016","unstructured":"Manabe, T. et al. Influence of pneumonia complications on the prognosis of patients with autopsy-confirmed Alzheimer\u2019s disease, dementia with Lewy bodies, and vascular dementia. Psychogeriatrics 16, 305\u2013314 (2016).","journal-title":"Psychogeriatrics"},{"key":"68580_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.701899","volume":"13","author":"H Ou","year":"2021","unstructured":"Ou, H. et al. Association between antibiotic treatment of chlamydia pneumoniae and reduced risk of Alzheimer dementia: a nationwide cohort study in Taiwan. Front. Aging Neurosci. 13, 701899 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"68580_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06749-9","volume":"12","author":"A Chacko","year":"2022","unstructured":"Chacko, A. et al. Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer\u2019s disease risk. Sci. Rep. 12, 2759 (2022).","journal-title":"Sci. Rep."},{"key":"68580_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0197-4580(03)00127-1","volume":"25","author":"CS Little","year":"2004","unstructured":"Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J. & Appelt, D. M. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB\/c mice. Neurobiol. Aging 25, 419\u2013429 (2004).","journal-title":"Neurobiol. Aging"},{"key":"68580_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fnagi.2014.00304","volume":"6","author":"CS Little","year":"2014","unstructured":"Little, C. S. et al. Detection of bacterial antigens and Alzheimer\u2019s disease-like pathology in the central nervous system of BALB\/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front. Aging Neurosci. 6, 304 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"68580_CR21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2019.00754","volume":"10","author":"TR Crother","year":"2019","unstructured":"Crother, T. R. et al. Autophagy limits inflammasome during chlamydia pneumoniae infection. Front. Immunol. 10, 754 (2019).","journal-title":"Front. Immunol."},{"key":"68580_CR22","doi-asserted-by":"publisher","first-page":"e21477","DOI":"10.1371\/journal.pone.0021477","volume":"6","author":"K Shimada","year":"2011","unstructured":"Shimada, K. et al. Caspase-1 dependent IL-1beta secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection. PLoS ONE 6, e21477 (2011).","journal-title":"PLoS ONE"},{"key":"68580_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701282","volume":"12","author":"H Bai","year":"2021","unstructured":"Bai, H. & Zhang, Q. Activation of NLRP3 Inflammasome and Onset of Alzheimer\u2019s Disease. Front. Immunol. 12, 701282 (2021).","journal-title":"Front. Immunol."},{"key":"68580_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13024-023-00674-9","volume":"18","author":"G Terzioglu","year":"2023","unstructured":"Terzioglu, G. & Young-Pearse, T. L. Microglial function, INPP5D\/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer\u2019s disease. Mol. Neurodegener. 18, 89 (2023).","journal-title":"Mol. Neurodegener."},{"key":"68580_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-020-0145-7","volume":"5","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Dong, Z. & Song, W. NLRP3 inflammasome as a novel therapeutic target for Alzheimer\u2019s disease. Signal. Transduct. Target Ther. 5, 37 (2020).","journal-title":"Signal. Transduct. Target Ther."},{"key":"68580_CR26","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka, M. T. et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493, 674\u2013678 (2013).","journal-title":"Nature"},{"key":"68580_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising, C. et al. NLRP3 inflammasome activation drives tau pathology. Nature 575, 669\u2013673 (2019).","journal-title":"Nature"},{"key":"68580_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","volume":"11","author":"M Saresella","year":"2016","unstructured":"Saresella, M. et al. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer\u2019s disease. Mol. Neurodegener. 11, 23 (2016).","journal-title":"Mol. Neurodegener."},{"key":"68580_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","volume":"23","author":"L Vande Walle","year":"2024","unstructured":"Vande Walle, L. & Lamkanfi, M. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat. Rev. Drug Discov. 23, 43\u201366 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"68580_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101273","volume":"101","author":"BP Gaire","year":"2024","unstructured":"Gaire, B. P. et al. Alzheimer\u2019s disease pathophysiology in the Retina. Prog. Retin Eye Res 101, 101273 (2024).","journal-title":"Prog. Retin Eye Res"},{"key":"68580_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12242-1","volume":"10","author":"X Hadoux","year":"2019","unstructured":"Hadoux, X. et al. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer\u2019s disease. Nat. Commun. 10, 4227 (2019).","journal-title":"Nat. Commun."},{"key":"68580_CR32","doi-asserted-by":"publisher","unstructured":"Koronyo, Y. et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight 2, https:\/\/doi.org\/10.1172\/jci.insight.93621 (2017).","DOI":"10.1172\/jci.insight.93621"},{"key":"68580_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-023-02548-2","volume":"145","author":"Y Koronyo","year":"2023","unstructured":"Koronyo, Y. et al. Retinal pathological features and proteome signatures of Alzheimer\u2019s disease. Acta Neuropathol. 145, 409\u2013438 (2023).","journal-title":"Acta Neuropathol."},{"key":"68580_CR34","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui, M. et al. Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54, S204\u2013S217 (2011).","journal-title":"Neuroimage"},{"key":"68580_CR35","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fnins.2020.00758","volume":"14","author":"S Lee","year":"2020","unstructured":"Lee, S. et al. Amyloid beta immunoreactivity in the retinal ganglion cell layer of the Alzheimer\u2019s eye. Front. Neurosci. 14, 758 (2020).","journal-title":"Front. Neurosci."},{"key":"68580_CR36","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00401-020-02134-w","volume":"139","author":"H Shi","year":"2020","unstructured":"Shi, H. et al. Identification of early pericyte loss and vascular amyloidosis in Alzheimer\u2019s disease retina. Acta Neuropathol. 139, 813\u2013836 (2020).","journal-title":"Acta Neuropathol."},{"key":"68580_CR37","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3233\/JAD-210327","volume":"83","author":"K Tadokoro","year":"2021","unstructured":"Tadokoro, K. et al. Retinal amyloid imaging for screening Alzheimer\u2019s disease. J. Alzheimers Dis. 83, 927\u2013934 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"68580_CR38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/alz.13424","volume":"20","author":"G Walkiewicz","year":"2024","unstructured":"Walkiewicz, G. et al. Primary retinal tauopathy: a tauopathy with a distinct molecular pattern. Alzheimers Dement 20, 330\u2013340 (2024).","journal-title":"Alzheimers Dement"},{"key":"68580_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-025-01935-y","volume":"13","author":"MR Davis","year":"2025","unstructured":"Davis, M. R. et al. Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer\u2019s disease. Acta Neuropathol. Commun. 13, 31 (2025).","journal-title":"Acta Neuropathol. Commun."},{"key":"68580_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00401-024-02760-8","volume":"148","author":"H Shi","year":"2024","unstructured":"Shi, H. et al. Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status. Acta Neuropathol. 148, 3 (2024).","journal-title":"Acta Neuropathol."},{"key":"68580_CR41","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1002\/alz.13086","volume":"19","author":"H Shi","year":"2023","unstructured":"Shi, H. et al. Retinal arterial Abeta(40) deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients. Alzheimers Dement 19, 5185\u20135197 (2023).","journal-title":"Alzheimers Dement"},{"key":"68580_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70592","volume":"21","author":"P Wijesinghe","year":"2025","unstructured":"Wijesinghe, P. et al. Decoding amyloid beta clearance systems at inner blood-retina barrier using three-dimensional ex vivo retinal imaging in Alzheimer\u2019s disease. Alzheimers Dement 21, e70592 (2025).","journal-title":"Alzheimers Dement"},{"key":"68580_CR43","doi-asserted-by":"publisher","unstructured":"Cao, Q. et al. Transport of beta-amyloid from brain to eye causes retinal degeneration in Alzheimer\u2019s disease. J. Exp. Med. 221, https:\/\/doi.org\/10.1084\/jem.20240386 (2024).","DOI":"10.1084\/jem.20240386"},{"key":"68580_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40478-022-01448-y","volume":"10","author":"QA Xu","year":"2022","unstructured":"Xu, Q. A. et al. Muller cell degeneration and microglial dysfunction in the Alzheimer\u2019s retina. Acta Neuropathol. Commun. 10, 145 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"68580_CR45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/alz.12179","volume":"17","author":"PJ Snyder","year":"2021","unstructured":"Snyder, P. J. et al. Retinal imaging in Alzheimer\u2019s and neurodegenerative diseases. Alzheimers Dement 17, 103\u2013111 (2021).","journal-title":"Alzheimers Dement"},{"key":"68580_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54715-y","volume":"16","author":"Y Gong","year":"2025","unstructured":"Gong, Y. et al. Stereo-seq of the prefrontal cortex in aging and Alzheimer\u2019s disease. Nat. Commun. 16, 482 (2025).","journal-title":"Nat. Commun."},{"key":"68580_CR47","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3233\/JAD-200303","volume":"76","author":"R Muzambi","year":"2020","unstructured":"Muzambi, R. et al. Common bacterial infections and risk of dementia or cognitive decline: a systematic review. J. Alzheimers Dis. 76, 1609\u20131626 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"68580_CR48","doi-asserted-by":"publisher","first-page":"e1004883","DOI":"10.1371\/journal.ppat.1004883","volume":"11","author":"L Aeberhard","year":"2015","unstructured":"Aeberhard, L. et al. The proteome of the isolated chlamydia trachomatis containing vacuole reveals a complex trafficking platform enriched for retromer components. PLoS Pathog. 11, e1004883 (2015).","journal-title":"PLoS Pathog."},{"key":"68580_CR49","doi-asserted-by":"publisher","first-page":"e1007698","DOI":"10.1371\/journal.ppat.1007698","volume":"15","author":"MS Dickinson","year":"2019","unstructured":"Dickinson, M. S. et al. Proximity-dependent proteomics of the Chlamydia trachomatis inclusion membrane reveals functional interactions with endoplasmic reticulum exit sites. PLoS Pathog. 15, e1007698 (2019).","journal-title":"PLoS Pathog."},{"key":"68580_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.chom.2015.06.004","volume":"18","author":"KM Mirrashidi","year":"2015","unstructured":"Mirrashidi, K. M. et al. Global mapping of the inc-human interactome reveals that retromer restricts chlamydia infection. Cell Host Microbe 18, 109\u2013121 (2015).","journal-title":"Cell Host Microbe"},{"key":"68580_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2019.103595","volume":"212","author":"MG Olson","year":"2020","unstructured":"Olson, M. G., Ouellette, S. P. & Rucks, E. A. A meta-analysis of affinity purification-mass spectrometry experimental systems used to identify eukaryotic and chlamydial proteins at the Chlamydia trachomatis inclusion membrane. J. Proteom. 212, 103595 (2020).","journal-title":"J. Proteom."},{"key":"68580_CR52","doi-asserted-by":"crossref","unstructured":"Olson, M. G. et al. Proximity labeling to map host-pathogen interactions at the membrane of a bacterium-containing vacuole in chlamydia trachomatis-infected human cells. Infect Immun. 87, e00537\u201319 (2019).","DOI":"10.1128\/IAI.00537-19"},{"key":"68580_CR53","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.4049\/jimmunol.1901508","volume":"204","author":"R Karki","year":"2020","unstructured":"Karki, R., Lee, E., Sharma, B. R., Banoth, B. & Kanneganti, T. D. IRF8 regulates gram-negative bacteria-mediated NLRP3 inflammasome activation and cell death. J. Immunol. 204, 2514\u20132522 (2020).","journal-title":"J. Immunol."},{"key":"68580_CR54","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cell.2012.07.007","volume":"150","author":"VA Rathinam","year":"2012","unstructured":"Rathinam, V. A. et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 150, 606\u2013619 (2012).","journal-title":"Cell"},{"key":"68580_CR55","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.4049\/jimmunol.0802260","volume":"182","author":"P Dai","year":"2009","unstructured":"Dai, P. et al. Modulation of TLR signaling by multiple MyD88-interacting partners, including leucine-rich repeat Fli-I-interacting proteins. J. Immunol. 182, 3450\u20133460 (2009).","journal-title":"J. Immunol."},{"key":"68580_CR56","doi-asserted-by":"crossref","unstructured":"Sun, R. et al. In silico identification and validation of pyroptosis-related genes in chlamydia respiratory infection. Int. J. Mol. Sci. 24, 13570 (2023).","DOI":"10.3390\/ijms241713570"},{"key":"68580_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-80988-0","volume":"11","author":"JP Vit","year":"2021","unstructured":"Vit, J. P. et al. Color and contrast vision in mouse models of aging and Alzheimer\u2019s disease using a novel visual-stimuli four-arm maze. Sci. Rep. 11, 1255 (2021).","journal-title":"Sci. Rep."},{"key":"68580_CR58","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cmet.2018.05.027","volume":"28","author":"G Tumurkhuu","year":"2018","unstructured":"Tumurkhuu, G. et al. Chlamydia pneumoniae hijacks a host autoregulatory IL-1beta loop to drive foam cell formation and accelerate atherosclerosis. Cell Metab. 28, 432\u2013448 e434 (2018).","journal-title":"Cell Metab."},{"key":"68580_CR59","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neurobiolaging.2006.02.014","volume":"28","author":"E Boelen","year":"2007","unstructured":"Boelen, E. et al. Chlamydia pneumoniae infection of brain cells: an in vitro study. Neurobiol. Aging 28, 524\u2013532 (2007).","journal-title":"Neurobiol. Aging"},{"key":"68580_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105684","volume":"167","author":"B Kenkhuis","year":"2022","unstructured":"Kenkhuis, B. et al. Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer\u2019s disease. Neurobiol. Dis. 167, 105684 (2022).","journal-title":"Neurobiol. Dis."},{"key":"68580_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12780-8","volume":"10","author":"M Menon","year":"2019","unstructured":"Menon, M. et al. Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration. Nat. Commun. 10, 4902 (2019).","journal-title":"Nat. Commun."},{"key":"68580_CR62","doi-asserted-by":"publisher","unstructured":"Yap, T. E., Donna, P., Almonte, M. T. & Cordeiro, M. F. Real-time imaging of retinal ganglion cell apoptosis. Cells 7, https:\/\/doi.org\/10.3390\/cells7060060 (2018).","DOI":"10.3390\/cells7060060"},{"key":"68580_CR63","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40478-024-01810-2","volume":"12","author":"OM Dumitrascu","year":"2024","unstructured":"Dumitrascu, O. M. et al. Retinal peri-arteriolar versus peri-venular amyloidosis, hippocampal atrophy, and cognitive impairment: exploratory trial. Acta Neuropathol. Commun. 12, 109 (2024).","journal-title":"Acta Neuropathol. Commun."},{"key":"68580_CR64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.micpath.2005.05.002","volume":"39","author":"HC Gerard","year":"2005","unstructured":"Gerard, H. C. et al. The load of Chlamydia pneumoniae in the Alzheimer\u2019s brain varies with APOE genotype. Micro. Pathog. 39, 19\u201326 (2005).","journal-title":"Micro. Pathog."},{"key":"68580_CR65","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1128\/CMR.8.4.451","volume":"8","author":"CC Kuo","year":"1995","unstructured":"Kuo, C. C., Jackson, L. A., Campbell, L. A. & Grayston, J. T. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8, 451\u2013461 (1995).","journal-title":"Clin. Microbiol. Rev."},{"key":"68580_CR66","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.3389\/fmicb.2018.03101","volume":"9","author":"ME Panzetta","year":"2018","unstructured":"Panzetta, M. E., Valdivia, R. H. & Saka, H. A. Chlamydia persistence: a survival strategy to evade antimicrobial effects in vitro and in vivo. Front. Microbiol. 9, 3101 (2018).","journal-title":"Front. Microbiol."},{"key":"68580_CR67","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-022-00359-5","volume":"8","author":"AW Solomon","year":"2022","unstructured":"Solomon, A. W. et al. Trachoma. Nat. Rev. Dis. Prim. 8, 32 (2022).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"68580_CR68","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","volume":"14","author":"RD Moir","year":"2018","unstructured":"Moir, R. D., Lathe, R. & Tanzi, R. E. The antimicrobial protection hypothesis of Alzheimer\u2019s disease. Alzheimers Dement 14, 1602\u20131614 (2018).","journal-title":"Alzheimers Dement"},{"key":"68580_CR69","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jacc.2018.01.072","volume":"71","author":"S Chen","year":"2018","unstructured":"Chen, S. et al. Chlamydia and lipids engage a common signaling pathway that promotes atherogenesis. J. Am. Coll. Cardiol. 71, 1553\u20131570 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"68580_CR70","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney, M. S. et al. APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature 628, 154\u2013161 (2024).","journal-title":"Nature"},{"key":"68580_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1186","volume":"9","author":"L Tang","year":"2020","unstructured":"Tang, L., Lu, C., Zheng, G. & Burgering, B. M. Emerging insights on the role of gasdermins in infection and inflammatory diseases. Clin. Transl. Immunol. 9, e1186 (2020).","journal-title":"Clin. Transl. Immunol."},{"key":"68580_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo, E. K., Kim, J. K., Shin, D. M. & Sasakawa, C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol. Immunol. 13, 148\u2013159 (2016).","journal-title":"Cell Mol. Immunol."},{"key":"68580_CR73","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","volume":"10","author":"R Chen","year":"2025","unstructured":"Chen, R. et al. Pattern recognition receptors: function, regulation and therapeutic potential. Signal Transduct. Target Ther. 10, 216 (2025).","journal-title":"Signal Transduct. Target Ther."},{"key":"68580_CR74","doi-asserted-by":"crossref","unstructured":"Kulczynska-Przybik, A. et al. The clinical significance of cerebrospinal fluid reticulon 4 (RTN4) levels in the differential diagnosis of neurodegenerative diseases. J. Clin. Med. 10, 5281 (2021).","DOI":"10.3390\/jcm10225281"},{"key":"68580_CR75","doi-asserted-by":"publisher","unstructured":"Pelucchi, S., Stringhi, R. & Marcello, E. Dendritic spines in Alzheimer\u2019s disease: How the actin cytoskeleton contributes to synaptic failure. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21030908 (2020).","DOI":"10.3390\/ijms21030908"},{"key":"68580_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk9884","volume":"10","author":"F Yang","year":"2024","unstructured":"Yang, F. et al. Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection. Sci. Adv. 10, eadk9884 (2024).","journal-title":"Sci. Adv."},{"key":"68580_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1049786","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Bioinformatics-based study reveals that AP2M1 is regulated by the circRNA-miRNA-mRNA interaction network and affects Alzheimer\u2019s disease. Front. Genet. 13, 1049786 (2022).","journal-title":"Front. Genet."},{"key":"68580_CR78","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/WAD.0000000000000279","volume":"32","author":"L Besser","year":"2018","unstructured":"Besser, L. et al. Version 3 of the National Alzheimer\u2019s Coordinating Center\u2019s uniform data set. Alzheimer Dis. Assoc. Disord. 32, 351\u2013358 (2018).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"68580_CR79","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris, J. C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412\u20132414 (1993).","journal-title":"Neurology"},{"key":"68580_CR80","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695\u2013699 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"68580_CR81","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. Mini-Mental State\u201d. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189\u2013198 (1975).","journal-title":"J. Psychiatr. Res."},{"key":"68580_CR82","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal, D. R., Rub, U., Orantes, M. & Braak, H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791\u20131800 (2002).","journal-title":"Neurology"},{"key":"68580_CR83","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H. & Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389\u2013404 (2006).","journal-title":"Acta Neuropathol."},{"key":"68580_CR84","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra, S. S. et al. The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41, 479\u2013486 (1991).","journal-title":"Neurology"},{"key":"68580_CR85","volume":"11","author":"JP Vit","year":"2021","unstructured":"Vit, J. P. et al. Visual-stimuli four-arm maze test to assess cognition and vision in mice. Biol. Protoc. 11, e4234 (2021).","journal-title":"Biol. Protoc."},{"key":"68580_CR86","doi-asserted-by":"publisher","first-page":"e1000379","DOI":"10.1371\/journal.ppat.1000379","volume":"5","author":"K Shimada","year":"2009","unstructured":"Shimada, K. et al. The NOD\/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection. PLoS Pathog. 5, e1000379 (2009).","journal-title":"PLoS Pathog."},{"key":"68580_CR87","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"68580_CR88","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"68580_CR89","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"Harris","year":"2020","unstructured":"Harris et al. Array programming with NumPy. Nature 585, 357\u2013362 (2020).","journal-title":"Nature"},{"key":"68580_CR90","unstructured":"URL1; https:\/\/pandas.pydata.org\/about\/citing.html (2025)."},{"key":"68580_CR91","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261\u2013272 (2020).","journal-title":"Nat. Methods"},{"key":"68580_CR92","doi-asserted-by":"publisher","unstructured":"Gaire, B. P. et al. Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer\u2019s disease retina Zenodo, https:\/\/doi.org\/10.5281\/zenodo.18021732 (2025).","DOI":"10.5281\/zenodo.18021732"},{"key":"68580_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70163","volume":"21","author":"NJ Brogaard","year":"2025","unstructured":"Brogaard, N. J. et al. Extension and external validation of mapping between the Mini-Mental State Examination and the Clinical Dementia Rating scale in patients with Alzheimer\u2019s disease. Alzheimers Dement 21, e70163 (2025).","journal-title":"Alzheimers Dement"},{"key":"68580_CR94","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun, M. A. et al. Donanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 384, 1691\u20131704 (2021).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68580-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:07:55Z","timestamp":1769213275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68580-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68580"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68580-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6658954\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2025.06.19.660619","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.K., K.L.B., and M.K.H. are co-founders of NeuroVision Imaging, Inc. NeuroVision Imaging had no role in study design, data collection, analysis, interpretation, or manuscript preparation, and this work is not related to any product or service of the company. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"771"}}